DOI: 10.1097/01.pcc.0000449238.18168.bd
,
Issn Print: 1529-7535
Publication Date: 2014/05/01
Facebook
Twitter
LinkedIn
Email
 |
Checking for direct PDF access through Ovid | |
Excerpt
Aims: However, determining disease causality of these sequence variants is much more challenging since many of the genes identified are novel to development. Therefore, initial analysis requires a validation step. Here we present a high throughput strategy for CHD research aimed at the discovery of causative genes and underlying developmental mechanisms.
Methods: Our goal is to use the small animal model, Xenopus tropicalis, to test candidate genes for effects on cardiac development. Xenopus is rapid and inexpensive allowing us to test many genes efficiently. To visualize abnormal cardiac structure, clinical cardiologists employ various imaging modalities. Similarly we sought to develop imaging methods for Xenopus cardiac phenotyping, which requires micro-scale imaging. We have applied optic coherence tomography and a novel hemoglobin contrast subtraction angiography to demonstrate high resolution, high-speed, in vivo cardiac phenotyping in Xenopus. (Approved by Yale Animal Care and Use Committee).
Results: Our method identified a novel gene, CRP3, in a patient with non-compaction cardiomyopathy and AV canal defect. When depleted in Xenopus, we discovered a cardiac phenotype including loss of trabeculations, compact-small ventricle and enlarged atria, resembling the human phenotype closely.
Conclusions: Our model and strategy aims to discover the causes of CHDs from patients that we see in the Pediatric/Neonatal Intensive Care Units.
